What question did this study set out to answer?

This research investigates how METTL3 promotes immune escape in pancreatic cancer by modifying AFAP1-AS1 to affect EGR2 stability.

February 8, 2026Open Access

METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability

Puntos clave

This research investigates how METTL3 promotes immune escape in pancreatic cancer by modifying AFAP1-AS1 to affect EGR2 stability.
Examined the role of METTL3 in relation to AFAP1-AS1 and EGR2 in pancreatic cancer cells.
Utilized m6A modification analysis to assess stability of lncRNA and mRNA.
Evaluated the impact of EGR2 on immune checkpoint and EMT-related gene transcription.
METTL3 enhances AFAP1-AS1 stability through m6A modification.
Increased EGR2 expression leads to upregulation of immune checkpoint and EMT genes.
The METTL3/AFAP1-AS1/EGR2 axis is implicated in pancreatic cancer malignancy and immune resistance.

Resumen

METTL3 enhances AFAP1-AS1 stability via m6A modification recognized by YTHDF2 and IGF2BP1, which subsequently increases EGR2 expression by improving its mRNA stability. EGR2 directly activates transcription of immune checkpoint and epithelial-mesenchymal transition (EMT)-related genes. This METTL3/AFAP1-AS1/EGR2 signaling axis drives PC malignancy and immune resistance, offering potential therapeutic targets for PC treatment.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Zhu et al. (Wed,) studied this question.

synapsesocial.com/papers/698827570fc35cd7a8845fef https://doi.org/https://doi.org/10.1186/s40001-026-03963-3

Me gusta

Guardar

Ver artículo completo